LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 60 filers reported holding LEAP THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,524,694 | +902.4% | 7,425,570 | +1226.7% | 0.01% | +600.0% |
Q4 2022 | $251,867 | -48.9% | 559,705 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $493,000 | -23.4% | 559,705 | 0.0% | 0.00% | -25.0% |
Q2 2022 | $644,000 | -34.2% | 559,705 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $979,000 | -46.0% | 559,705 | 0.0% | 0.01% | -33.3% |
Q4 2021 | $1,813,000 | -19.2% | 559,705 | 0.0% | 0.01% | -10.0% |
Q3 2021 | $2,244,000 | +144.4% | 559,705 | 0.0% | 0.01% | +150.0% |
Q2 2021 | $918,000 | -13.6% | 559,705 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $1,063,000 | -15.6% | 559,705 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $1,259,000 | +13.6% | 559,705 | 0.0% | 0.01% | +25.0% |
Q3 2020 | $1,108,000 | -45.8% | 559,705 | -42.8% | 0.00% | -55.6% |
Q2 2020 | $2,045,000 | +32.3% | 978,454 | 0.0% | 0.01% | -10.0% |
Q1 2020 | $1,546,000 | +41.1% | 978,454 | 0.0% | 0.01% | +66.7% |
Q4 2019 | $1,096,000 | -4.3% | 978,454 | 0.0% | 0.01% | -25.0% |
Q3 2019 | $1,145,000 | – | 978,454 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Key Client Fiduciary Advisors, LLC | 1,349,321 | $607,194 | 0.41% |
ELEMENT CAPITAL MANAGEMENT LLC | 1,158,551 | $521,348 | 0.31% |
Knott David M Jr | 840,000 | $378 | 0.14% |
683 Capital Management, LLC | 2,750,000 | $1,237,500 | 0.10% |
Artal Group S.A. | 4,000,000 | $1,800 | 0.10% |
Perceptive Advisors | 6,726,496 | $3,026,923 | 0.08% |
Rock Springs Capital Management LP | 3,659,847 | $1,646,931 | 0.04% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,327,952 | $597,578 | 0.02% |
McAdam, LLC | 32,784 | $106 | 0.01% |
Annandale Capital, LLC | 40,000 | $18 | 0.01% |